... has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and ...
... (CV) events (CV death, myocardial infarction or stroke) from 11.7% to 9.8% ... infarction, stroke, and total mortality; and a composite of cardiovascular death, myocardial infarction, stroke, transient ...
... was similar to that seen in patients with cardiac ischemia, the most well-known risk factor for cardiovascular death in patients with chronic kidney disease.
Dr. de Mattos and his team found that ...
... was 9.9 months.
There were 678 total deaths (307 of 1,641 patients [18. ... 28 percent increased risk for the composite of cardiovascular death or hospitalization for heart failure.
"In this analysis, ...
... the July 9 issue of JAMA. Major cardiovascular and cerebrovascular events including heart attack ... 4 percent, about a four times higher risk of cardiovascular death for men with low ABI. Corresponding ...
... , a consistent and robust association between a high blood level of alkaline phosphatase and cardiovascular death in thousands of dialysis patients across the United States," comments Kamyar Kalantar- ...
... protect sleep apnea patients against cardiovascular death.
"I was surprised by how much the risks ... adjustments show that high blood pressure, cardiovascular disease, stroke and diabetes may play a role ...
... the data showed that use of inhaled anticholinergics for more than one month significantly increased the risk of cardiovascular death, heart attacks, or strokes in COPD patients by 58 percent.
The ...
... day treatment for chronic obstructive pulmonary disease for longer than one month increases the risk of cardiovascular death, heart attack or stroke by more than 50 percent, according to new research. ...
... (COPD) is associated with a significantly increased risk of heart attack, stroke of cardiovascular death, according to a meta-analysis of randomised trials published in the 24 September issue of JAMA ...
... second non-fatal heart attack and other cardiovascular events, according to a report in the November 10 issue ... percent] in the usual care group), including cardiovascular death, non-fatal heart attack ...
... or not patients had received the GnRH agonist apparently had no effect on the risk of cardiovascular death. Instead, it was established cardiac risk factors – including heart disease or diabetes ...
... stroke had a 3 to 4 fold risk of cardiovascular death compared to men without either ... mortality risk compared with men with neither cardiovascular disease nor diabetes at the beginning of the follow- ...
... cardiovascular disease.
The researchers found that classic risk factors were unable to predict cardiovascular deaths accurately, neither by using the Framingham Risk Score nor by using the classic ...
... for death.
"The study found no difference in overall mortality between the two groups but cardiovascular death was significantly reduced with dronedarone by 29%. There was no difference in thyroid- ...
